1 Study Coverage 1.1 Labeled Peptides Product Introduction 1.2 Market by Type 1.2.1 Global Labeled Peptides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 (Arg)9, FAM-labeled 1.2.3 (Arg)9, TAMRA-labeled 1.2.4 Others 1.3 Market by Application 1.3.1 Global Labeled Peptides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Protein Chemistry 1.3.3 Immunology 1.3.4 Histochemistry 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Labeled Peptides Sales Estimates and Forecasts 2017-2028 2.2 Global Labeled Peptides Revenue Estimates and Forecasts 2017-2028 2.3 Global Labeled Peptides Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Labeled Peptides Sales by Region 2.4.1 Global Labeled Peptides Sales by Region (2017-2022) 2.4.2 Global Sales Labeled Peptides by Region (2023-2028) 2.5 Global Labeled Peptides Revenue by Region 2.5.1 Global Labeled Peptides Revenue by Region (2017-2022) 2.5.2 Global Labeled Peptides Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Labeled Peptides Sales by Manufacturers 3.1.1 Global Top Labeled Peptides Manufacturers by Sales (2017-2022) 3.1.2 Global Labeled Peptides Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Labeled Peptides in 2021 3.2 Global Labeled Peptides Revenue by Manufacturers 3.2.1 Global Labeled Peptides Revenue by Manufacturers (2017-2022) 3.2.2 Global Labeled Peptides Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Labeled Peptides Revenue in 2021 3.3 Global Labeled Peptides Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Labeled Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Labeled Peptides Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Labeled Peptides Sales by Type 4.1.1 Global Labeled Peptides Historical Sales by Type (2017-2022) 4.1.2 Global Labeled Peptides Forecasted Sales by Type (2023-2028) 4.1.3 Global Labeled Peptides Sales Market Share by Type (2017-2028) 4.2 Global Labeled Peptides Revenue by Type 4.2.1 Global Labeled Peptides Historical Revenue by Type (2017-2022) 4.2.2 Global Labeled Peptides Forecasted Revenue by Type (2023-2028) 4.2.3 Global Labeled Peptides Revenue Market Share by Type (2017-2028) 4.3 Global Labeled Peptides Price by Type 4.3.1 Global Labeled Peptides Price by Type (2017-2022) 4.3.2 Global Labeled Peptides Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Labeled Peptides Sales by Application 5.1.1 Global Labeled Peptides Historical Sales by Application (2017-2022) 5.1.2 Global Labeled Peptides Forecasted Sales by Application (2023-2028) 5.1.3 Global Labeled Peptides Sales Market Share by Application (2017-2028) 5.2 Global Labeled Peptides Revenue by Application 5.2.1 Global Labeled Peptides Historical Revenue by Application (2017-2022) 5.2.2 Global Labeled Peptides Forecasted Revenue by Application (2023-2028) 5.2.3 Global Labeled Peptides Revenue Market Share by Application (2017-2028) 5.3 Global Labeled Peptides Price by Application 5.3.1 Global Labeled Peptides Price by Application (2017-2022) 5.3.2 Global Labeled Peptides Price Forecast by Application (2023-2028) 6 North America 6.1 North America Labeled Peptides Market Size by Type 6.1.1 North America Labeled Peptides Sales by Type (2017-2028) 6.1.2 North America Labeled Peptides Revenue by Type (2017-2028) 6.2 North America Labeled Peptides Market Size by Application 6.2.1 North America Labeled Peptides Sales by Application (2017-2028) 6.2.2 North America Labeled Peptides Revenue by Application (2017-2028) 6.3 North America Labeled Peptides Market Size by Country 6.3.1 North America Labeled Peptides Sales by Country (2017-2028) 6.3.2 North America Labeled Peptides Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada 7 Europe 7.1 Europe Labeled Peptides Market Size by Type 7.1.1 Europe Labeled Peptides Sales by Type (2017-2028) 7.1.2 Europe Labeled Peptides Revenue by Type (2017-2028) 7.2 Europe Labeled Peptides Market Size by Application 7.2.1 Europe Labeled Peptides Sales by Application (2017-2028) 7.2.2 Europe Labeled Peptides Revenue by Application (2017-2028) 7.3 Europe Labeled Peptides Market Size by Country 7.3.1 Europe Labeled Peptides Sales by Country (2017-2028) 7.3.2 Europe Labeled Peptides Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Labeled Peptides Market Size by Type 8.1.1 Asia Pacific Labeled Peptides Sales by Type (2017-2028) 8.1.2 Asia Pacific Labeled Peptides Revenue by Type (2017-2028) 8.2 Asia Pacific Labeled Peptides Market Size by Application 8.2.1 Asia Pacific Labeled Peptides Sales by Application (2017-2028) 8.2.2 Asia Pacific Labeled Peptides Revenue by Application (2017-2028) 8.3 Asia Pacific Labeled Peptides Market Size by Region 8.3.1 Asia Pacific Labeled Peptides Sales by Region (2017-2028) 8.3.2 Asia Pacific Labeled Peptides Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Labeled Peptides Market Size by Type 9.1.1 Latin America Labeled Peptides Sales by Type (2017-2028) 9.1.2 Latin America Labeled Peptides Revenue by Type (2017-2028) 9.2 Latin America Labeled Peptides Market Size by Application 9.2.1 Latin America Labeled Peptides Sales by Application (2017-2028) 9.2.2 Latin America Labeled Peptides Revenue by Application (2017-2028) 9.3 Latin America Labeled Peptides Market Size by Country 9.3.1 Latin America Labeled Peptides Sales by Country (2017-2028) 9.3.2 Latin America Labeled Peptides Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Labeled Peptides Market Size by Type 10.1.1 Middle East and Africa Labeled Peptides Sales by Type (2017-2028) 10.1.2 Middle East and Africa Labeled Peptides Revenue by Type (2017-2028) 10.2 Middle East and Africa Labeled Peptides Market Size by Application 10.2.1 Middle East and Africa Labeled Peptides Sales by Application (2017-2028) 10.2.2 Middle East and Africa Labeled Peptides Revenue by Application (2017-2028) 10.3 Middle East and Africa Labeled Peptides Market Size by Country 10.3.1 Middle East and Africa Labeled Peptides Sales by Country (2017-2028) 10.3.2 Middle East and Africa Labeled Peptides Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Pepscan 11.1.1 Pepscan Corporation Information 11.1.2 Pepscan Overview 11.1.3 Pepscan Labeled Peptides Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Pepscan Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Pepscan Recent Developments 11.2 JPT Peptide Technologies 11.2.1 JPT Peptide Technologies Corporation Information 11.2.2 JPT Peptide Technologies Overview 11.2.3 JPT Peptide Technologies Labeled Peptides Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 JPT Peptide Technologies Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 JPT Peptide Technologies Recent Developments 11.3 PEPTIDE INSTITUTE 11.3.1 PEPTIDE INSTITUTE Corporation Information 11.3.2 PEPTIDE INSTITUTE Overview 11.3.3 PEPTIDE INSTITUTE Labeled Peptides Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 PEPTIDE INSTITUTE Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 PEPTIDE INSTITUTE Recent Developments 11.4 Merck 11.4.1 Merck Corporation Information 11.4.2 Merck Overview 11.4.3 Merck Labeled Peptides Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Merck Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Merck Recent Developments 11.5 BIOSYNTAN GmbH 11.5.1 BIOSYNTAN GmbH Corporation Information 11.5.2 BIOSYNTAN GmbH Overview 11.5.3 BIOSYNTAN GmbH Labeled Peptides Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 BIOSYNTAN GmbH Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 BIOSYNTAN GmbH Recent Developments 11.6 LifeTein 11.6.1 LifeTein Corporation Information 11.6.2 LifeTein Overview 11.6.3 LifeTein Labeled Peptides Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 LifeTein Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 LifeTein Recent Developments 11.7 Eurogentec 11.7.1 Eurogentec Corporation Information 11.7.2 Eurogentec Overview 11.7.3 Eurogentec Labeled Peptides Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Eurogentec Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Eurogentec Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Labeled Peptides Industry Chain Analysis 12.2 Labeled Peptides Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Labeled Peptides Production Mode & Process 12.4 Labeled Peptides Sales and Marketing 12.4.1 Labeled Peptides Sales Channels 12.4.2 Labeled Peptides Distributors 12.5 Labeled Peptides Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Labeled Peptides Industry Trends 13.2 Labeled Peptides Market Drivers 13.3 Labeled Peptides Market Challenges 13.4 Labeled Peptides Market Restraints 14 Key Findings in The Global Labeled Peptides Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Labeled Peptides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of (Arg)9, FAM-labeled Table 3. Major Manufacturers of (Arg)9, TAMRA-labeled Table 4. Major Manufacturers of Others Table 5. Global Labeled Peptides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Labeled Peptides Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Labeled Peptides Sales by Region (2017-2022) & (K Units) Table 8. Global Labeled Peptides Sales Market Share by Region (2017-2022) Table 9. Global Labeled Peptides Sales by Region (2023-2028) & (K Units) Table 10. Global Labeled Peptides Sales Market Share by Region (2023-2028) Table 11. Global Labeled Peptides Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Labeled Peptides Revenue Market Share by Region (2017-2022) Table 13. Global Labeled Peptides Revenue by Region (2023-2028) & (US$ Million) Table 14. Global Labeled Peptides Revenue Market Share by Region (2023-2028) Table 15. Global Labeled Peptides Sales by Manufacturers (2017-2022) & (K Units) Table 16. Global Labeled Peptides Sales Share by Manufacturers (2017-2022) Table 17. Global Labeled Peptides Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global Labeled Peptides Revenue Share by Manufacturers (2017-2022) Table 19. Labeled Peptides Price by Manufacturers (2017-2022) &(US$/Unit) Table 20. Global Labeled Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Labeled Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Labeled Peptides as of 2021) Table 22. Labeled Peptides Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Labeled Peptides Product Offered Table 24. Date of Manufacturers Enter into Labeled Peptides Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Labeled Peptides Sales by Type (2017-2022) & (K Units) Table 27. Global Labeled Peptides Sales by Type (2023-2028) & (K Units) Table 28. Global Labeled Peptides Sales Share by Type (2017-2022) Table 29. Global Labeled Peptides Sales Share by Type (2023-2028) Table 30. Global Labeled Peptides Revenue by Type (2017-2022) & (US$ Million) Table 31. Global Labeled Peptides Revenue by Type (2023-2028) & (US$ Million) Table 32. Global Labeled Peptides Revenue Share by Type (2017-2022) Table 33. Global Labeled Peptides Revenue Share by Type (2023-2028) Table 34. Labeled Peptides Price by Type (2017-2022) & (US$/Unit) Table 35. Global Labeled Peptides Price Forecast by Type (2023-2028) & (US$/Unit) Table 36. Global Labeled Peptides Sales by Application (2017-2022) & (K Units) Table 37. Global Labeled Peptides Sales by Application (2023-2028) & (K Units) Table 38. Global Labeled Peptides Sales Share by Application (2017-2022) Table 39. Global Labeled Peptides Sales Share by Application (2023-2028) Table 40. Global Labeled Peptides Revenue by Application (2017-2022) & (US$ Million) Table 41. Global Labeled Peptides Revenue by Application (2023-2028) & (US$ Million) Table 42. Global Labeled Peptides Revenue Share by Application (2017-2022) Table 43. Global Labeled Peptides Revenue Share by Application (2023-2028) Table 44. Labeled Peptides Price by Application (2017-2022) & (US$/Unit) Table 45. Global Labeled Peptides Price Forecast by Application (2023-2028) & (US$/Unit) Table 46. North America Labeled Peptides Sales by Type (2017-2022) & (K Units) Table 47. North America Labeled Peptides Sales by Type (2023-2028) & (K Units) Table 48. North America Labeled Peptides Revenue by Type (2017-2022) & (US$ Million) Table 49. North America Labeled Peptides Revenue by Type (2023-2028) & (US$ Million) Table 50. North America Labeled Peptides Sales by Application (2017-2022) & (K Units) Table 51. North America Labeled Peptides Sales by Application (2023-2028) & (K Units) Table 52. North America Labeled Peptides Revenue by Application (2017-2022) & (US$ Million) Table 53. North America Labeled Peptides Revenue by Application (2023-2028) & (US$ Million) Table 54. North America Labeled Peptides Sales by Country (2017-2022) & (K Units) Table 55. North America Labeled Peptides Sales by Country (2023-2028) & (K Units) Table 56. North America Labeled Peptides Revenue by Country (2017-2022) & (US$ Million) Table 57. North America Labeled Peptides Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe Labeled Peptides Sales by Type (2017-2022) & (K Units) Table 59. Europe Labeled Peptides Sales by Type (2023-2028) & (K Units) Table 60. Europe Labeled Peptides Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe Labeled Peptides Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe Labeled Peptides Sales by Application (2017-2022) & (K Units) Table 63. Europe Labeled Peptides Sales by Application (2023-2028) & (K Units) Table 64. Europe Labeled Peptides Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe Labeled Peptides Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe Labeled Peptides Sales by Country (2017-2022) & (K Units) Table 67. Europe Labeled Peptides Sales by Country (2023-2028) & (K Units) Table 68. Europe Labeled Peptides Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe Labeled Peptides Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific Labeled Peptides Sales by Type (2017-2022) & (K Units) Table 71. Asia Pacific Labeled Peptides Sales by Type (2023-2028) & (K Units) Table 72. Asia Pacific Labeled Peptides Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific Labeled Peptides Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific Labeled Peptides Sales by Application (2017-2022) & (K Units) Table 75. Asia Pacific Labeled Peptides Sales by Application (2023-2028) & (K Units) Table 76. Asia Pacific Labeled Peptides Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific Labeled Peptides Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific Labeled Peptides Sales by Region (2017-2022) & (K Units) Table 79. Asia Pacific Labeled Peptides Sales by Region (2023-2028) & (K Units) Table 80. Asia Pacific Labeled Peptides Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific Labeled Peptides Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America Labeled Peptides Sales by Type (2017-2022) & (K Units) Table 83. Latin America Labeled Peptides Sales by Type (2023-2028) & (K Units) Table 84. Latin America Labeled Peptides Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America Labeled Peptides Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America Labeled Peptides Sales by Application (2017-2022) & (K Units) Table 87. Latin America Labeled Peptides Sales by Application (2023-2028) & (K Units) Table 88. Latin America Labeled Peptides Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America Labeled Peptides Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America Labeled Peptides Sales by Country (2017-2022) & (K Units) Table 91. Latin America Labeled Peptides Sales by Country (2023-2028) & (K Units) Table 92. Latin America Labeled Peptides Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America Labeled Peptides Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa Labeled Peptides Sales by Type (2017-2022) & (K Units) Table 95. Middle East and Africa Labeled Peptides Sales by Type (2023-2028) & (K Units) Table 96. Middle East and Africa Labeled Peptides Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa Labeled Peptides Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa Labeled Peptides Sales by Application (2017-2022) & (K Units) Table 99. Middle East and Africa Labeled Peptides Sales by Application (2023-2028) & (K Units) Table 100. Middle East and Africa Labeled Peptides Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa Labeled Peptides Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa Labeled Peptides Sales by Country (2017-2022) & (K Units) Table 103. Middle East and Africa Labeled Peptides Sales by Country (2023-2028) & (K Units) Table 104. Middle East and Africa Labeled Peptides Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa Labeled Peptides Revenue by Country (2023-2028) & (US$ Million) Table 106. Pepscan Corporation Information Table 107. Pepscan Description and Major Businesses Table 108. Pepscan Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 109. Pepscan Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Pepscan Recent Developments Table 111. JPT Peptide Technologies Corporation Information Table 112. JPT Peptide Technologies Description and Major Businesses Table 113. JPT Peptide Technologies Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 114. JPT Peptide Technologies Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications Table 115. JPT Peptide Technologies Recent Developments Table 116. PEPTIDE INSTITUTE Corporation Information Table 117. PEPTIDE INSTITUTE Description and Major Businesses Table 118. PEPTIDE INSTITUTE Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 119. PEPTIDE INSTITUTE Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications Table 120. PEPTIDE INSTITUTE Recent Developments Table 121. Merck Corporation Information Table 122. Merck Description and Major Businesses Table 123. Merck Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 124. Merck Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Merck Recent Developments Table 126. BIOSYNTAN GmbH Corporation Information Table 127. BIOSYNTAN GmbH Description and Major Businesses Table 128. BIOSYNTAN GmbH Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 129. BIOSYNTAN GmbH Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications Table 130. BIOSYNTAN GmbH Recent Developments Table 131. LifeTein Corporation Information Table 132. LifeTein Description and Major Businesses Table 133. LifeTein Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 134. LifeTein Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications Table 135. LifeTein Recent Developments Table 136. Eurogentec Corporation Information Table 137. Eurogentec Description and Major Businesses Table 138. Eurogentec Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 139. Eurogentec Labeled Peptides Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Eurogentec Recent Developments Table 141. Key Raw Materials Lists Table 142. Raw Materials Key Suppliers Lists Table 143. Labeled Peptides Distributors List Table 144. Labeled Peptides Customers List Table 145. Labeled Peptides Market Trends Table 146. Labeled Peptides Market Drivers Table 147. Labeled Peptides Market Challenges Table 148. Labeled Peptides Market Restraints Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Labeled Peptides Product Picture Figure 3. Global Labeled Peptides Market Share by Type in 2021 & 2028 Figure 3. (Arg)9, FAM-labeled Product Picture Figure 4. (Arg)9, TAMRA-labeled Product Picture Figure 5. Others Product Picture Figure 6. Global Labeled Peptides Market Share by Application in 2021 & 2028 Figure 7. Protein Chemistry Figure 8. Immunology Figure 9. Histochemistry Figure 10. Others Figure 11. Labeled Peptides Report Years Considered Figure 12. Global Labeled Peptides Sales 2017-2028 (K Units) Figure 13. Global Labeled Peptides Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Labeled Peptides Revenue 2017-2028 (US$ Million) Figure 15. Global Labeled Peptides Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 16. Global Labeled Peptides Sales Market Share by Region (2017-2022) Figure 17. Global Labeled Peptides Sales Market Share by Region (2023-2028) Figure 18. North America Labeled Peptides Sales YoY (2017-2028) & (K Units) Figure 19. North America Labeled Peptides Revenue YoY (2017-2028) & (US$ Million) Figure 20. Europe Labeled Peptides Sales YoY (2017-2028) & (K Units) Figure 21. Europe Labeled Peptides Revenue YoY (2017-2028) & (US$ Million) Figure 22. Asia-Pacific Labeled Peptides Sales YoY (2017-2028) & (K Units) Figure 23. Asia-Pacific Labeled Peptides Revenue YoY (2017-2028) & (US$ Million) Figure 24. Latin America Labeled Peptides Sales YoY (2017-2028) & (K Units) Figure 25. Latin America Labeled Peptides Revenue YoY (2017-2028) & (US$ Million) Figure 26. Middle East & Africa Labeled Peptides Sales YoY (2017-2028) & (K Units) Figure 27. Middle East & Africa Labeled Peptides Revenue YoY (2017-2028) & (US$ Million) Figure 28. The Labeled Peptides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 29. The Top 5 and 10 Largest Manufacturers of Labeled Peptides in the World: Market Share by Labeled Peptides Revenue in 2021 Figure 30. Global Labeled Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 31. Global Labeled Peptides Sales Market Share by Type (2017-2028) Figure 32. Global Labeled Peptides Revenue Market Share by Type (2017-2028) Figure 33. Global Labeled Peptides Sales Market Share by Application (2017-2028) Figure 34. Global Labeled Peptides Revenue Market Share by Application (2017-2028) Figure 35. North America Labeled Peptides Sales Market Share by Type (2017-2028) Figure 36. North America Labeled Peptides Revenue Market Share by Type (2017-2028) Figure 37. North America Labeled Peptides Sales Market Share by Application (2017-2028) Figure 38. North America Labeled Peptides Revenue Market Share by Application (2017-2028) Figure 39. North America Labeled Peptides Sales Share by Country (2017-2028) Figure 40. North America Labeled Peptides Revenue Share by Country (2017-2028) Figure 41. United States Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 42. Canada Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 43. Europe Labeled Peptides Sales Market Share by Type (2017-2028) Figure 44. Europe Labeled Peptides Revenue Market Share by Type (2017-2028) Figure 45. Europe Labeled Peptides Sales Market Share by Application (2017-2028) Figure 46. Europe Labeled Peptides Revenue Market Share by Application (2017-2028) Figure 47. Europe Labeled Peptides Sales Share by Country (2017-2028) Figure 48. Europe Labeled Peptides Revenue Share by Country (2017-2028) Figure 49. Germany Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 50. France Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 51. U.K. Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 52. Italy Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 53. Russia Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 54. Asia Pacific Labeled Peptides Sales Market Share by Type (2017-2028) Figure 55. Asia Pacific Labeled Peptides Revenue Market Share by Type (2017-2028) Figure 56. Asia Pacific Labeled Peptides Sales Market Share by Application (2017-2028) Figure 57. Asia Pacific Labeled Peptides Revenue Market Share by Application (2017-2028) Figure 58. Asia Pacific Labeled Peptides Sales Share by Region (2017-2028) Figure 59. Asia Pacific Labeled Peptides Revenue Share by Region (2017-2028) Figure 60. China Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 61. Japan Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 62. South Korea Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 63. India Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 64. Australia Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 65. China Taiwan Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 66. Indonesia Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 67. Thailand Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 68. Malaysia Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 69. Latin America Labeled Peptides Sales Market Share by Type (2017-2028) Figure 70. Latin America Labeled Peptides Revenue Market Share by Type (2017-2028) Figure 71. Latin America Labeled Peptides Sales Market Share by Application (2017-2028) Figure 72. Latin America Labeled Peptides Revenue Market Share by Application (2017-2028) Figure 73. Latin America Labeled Peptides Sales Share by Country (2017-2028) Figure 74. Latin America Labeled Peptides Revenue Share by Country (2017-2028) Figure 75. Mexico Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 76. Brazil Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 77. Argentina Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 78. Middle East and Africa Labeled Peptides Sales Market Share by Type (2017-2028) Figure 79. Middle East and Africa Labeled Peptides Revenue Market Share by Type (2017-2028) Figure 80. Middle East and Africa Labeled Peptides Sales Market Share by Application (2017-2028) Figure 81. Middle East and Africa Labeled Peptides Revenue Market Share by Application (2017-2028) Figure 82. Middle East and Africa Labeled Peptides Sales Share by Country (2017-2028) Figure 83. Middle East and Africa Labeled Peptides Revenue Share by Country (2017-2028) Figure 84. Turkey Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 85. Saudi Arabia Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 86. UAE Labeled Peptides Revenue (2017-2028) & (US$ Million) Figure 87. Labeled Peptides Value Chain Figure 88. Labeled Peptides Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Pepscan JPT Peptide Technologies PEPTIDE INSTITUTE Merck BIOSYNTAN GmbH LifeTein Eurogentec